GAULT CHERYL (Chief Operating Officer) sold 1.2% of their position (2.01K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $58.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/9/2026ACC: 0001193125-26-098488
Officer· Chief Operating Officer
Since Mar 2026
-2.01K
Net shares
Net seller
$58.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.01K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.01K
Price / share
$28.93
Trade value
$58.27K
% of position
1.2%
3/5/2026
171.93K→169.91K
Total
Net shares
−2.01K
Net value
-$58.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2026 | S · Sale | −2.01K | $28.93 | $58.27K | 1.2% | 171.93K | 169.91K |
| Total | −2.01K | -$58.27K | ||||||
Derivative Transactions0
No derivative transactions reported